Envoy Medical (NASDAQ:COCH) Stock Price Expected to Rise, Ascendiant Capital Markets Analyst Says

Envoy Medical (NASDAQ:COCH) had its price target raised by Ascendiant Capital Markets from $9.00 to $9.25 in a research report sent to investors on Monday,Benzinga reports. Ascendiant Capital Markets currently has a buy rating on the stock.

Envoy Medical Trading Down 2.2 %

Shares of COCH opened at $1.31 on Monday. The firm has a market cap of $27.94 million, a PE ratio of -0.93 and a beta of 2.35. Envoy Medical has a 1-year low of $1.21 and a 1-year high of $5.77. The firm has a fifty day simple moving average of $1.38 and a two-hundred day simple moving average of $1.77.

Envoy Medical (NASDAQ:COCH) last posted its quarterly earnings data on Friday, March 28th. The company reported ($0.45) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.12). The company had revenue of $0.04 million during the quarter, compared to the consensus estimate of $0.07 million. As a group, research analysts forecast that Envoy Medical will post -1.21 EPS for the current fiscal year.

Institutional Trading of Envoy Medical

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in COCH. Citadel Advisors LLC bought a new stake in shares of Envoy Medical during the 4th quarter valued at $42,000. CIBC Private Wealth Group LLC purchased a new position in Envoy Medical during the fourth quarter valued at $65,000. Lake Street Advisors Group LLC purchased a new position in Envoy Medical during the fourth quarter valued at $65,000. Finally, DSG Capital Advisors LLC bought a new stake in Envoy Medical during the fourth quarter valued at about $234,000. 8.59% of the stock is owned by hedge funds and other institutional investors.

About Envoy Medical

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.